The effect of therapeutic horseback riding on balance, spasticity and general well being on patients after stroke / non-congenital brain injuries

The effect of therapeutic horseback riding on balance, spasticity and general well being on patients after stroke / non-congenital brain injuries - The effect of therapeutic horseback riding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31177

Enrollment

Registered

2007-10-09

Start date

2007-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovasculair accident stroke

Interventions

Four therapeutic horseback riding sessions of at least 20 minutes and maximal 30 minutes each are provided. Prior to the intervention, subjects will be shown a video of the therapy to reduce adverse

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - at least 3 months post stroke or brain injury - report spasticity in knee extensors, - flexors or hip adductor group - sufficient balance to sit on a horse independently - stable medical condition

Exclusion criteria

Exclusion criteria: - allergy to latex or horses - insufficient cognitive capabilities to understand instructions - problems with communication for understanding instructions and feedback - severe contractures

Design outcomes

Primary

Measure	Time frame
Various parameters will be compared between baseline and time of measurement after intervention. The interventiongroup will also be compared with the controlgroup. The most important parameters are Berg Balance Scale, EMG-pattern and the Ashworth Scale. Furthermore, the VAS-scale, Borg-scale, Clonus score, Spasme Frequency Scale, SF-36, Falls Efficacy Scale and the Timed Up & Go test will be measured and compared.	—

Measure

Time frame

Various parameters will be compared between baseline and time of measurement after intervention. The interventiongroup will also be compared with the controlgroup. The most important parameters are Berg Balance Scale, EMG-pattern and the Ashworth Scale. Furthermore, the VAS-scale, Borg-scale, Clonus score, Spasme Frequency Scale, SF-36, Falls Efficacy Scale and the Timed Up & Go test will be measured and compared.

—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)